Polypoidal Choroidal Vasculopathy – A Type I Polypoidal Subretinal Neovasculopathy

por Kokame, Gregg T
Publicado 2013

Long term observation of hydrogel buckle intrusion without vision loss

por Kokame, Gregg T., McCarthy, Kayne
Publicado 2021

Polypoidal Choroidal Vasculopathy in Highly Myopic Eyes with Elongated Axial Length

por Kokame, Gregg T., Tom, Elysse S., Shantha, Jessica G., Kaneko, Kyle N.
Publicado 2017

In office management of optic capture of scleral fixated posterior chamber intraocular lenses

por Kokame, Gregg T., Card, Kevin, Pisig, Alex U., Shantha, Jessica G.
Publicado 2022

Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results

por Kokame, Gregg T., Lai, James C., Wee, Raymond, Yanagihara, Ryan, Shantha, Jessica G., Ayabe, Julia, Hirai, Kelsi
Publicado 2016

Evolving treatment paradigms for PCV

por Fenner, Beau J., Cheung, Chui Ming Gemmy, Sim, Shaun S., Lee, Won Ki, Staurenghi, Giovanni, Lai, Timothy Y. Y., Ruamviboonsuk, Paisan, Kokame, Gregg, Yanagi, Yasuo, Teo, Kelvin Y. C.
Publicado 2021

Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK

por Ogura, Yuichiro, Jaffe, Glenn J, Cheung, Chui Ming Gemmy, Kokame, Gregg T, Iida, Tomohiro, Takahashi, Kanji, Lee, Won Ki, Chang, Andrew A, Monés, Jordi, D’Souza, Divya, Weissgerber, Georges, Gedif, Kinfemichael, Koh, Adrian
Publicado 2022